Abstract:
Continuous blood-status monitoring by thoracic impedance or impedance phase measurement [1] is critical in reducing chronic heart failure (CHF) because the symptoms of de...Show MoreMetadata
Abstract:
Continuous blood-status monitoring by thoracic impedance or impedance phase measurement [1] is critical in reducing chronic heart failure (CHF) because the symptoms of deterioration are not recognized by patients, thus preventing timely treatment. Therefore, a wearable/implantable bio-impedance (Bio-Z) sensor is required for ambulatory patients to detect early signs of deterioration for appropriate intervention in proper time. Continuous monitoring requires ultralow-power consumption (<10μW) and it requires the high resolution (<0.1Ω) to detect small impedance variations [2]. Prior Bio-Z sensor ICs [2–4] do not satisfy these requirements simultaneously because the resolution depends inversely on the power consumption. Furthermore, previous Bio-Z sensors have a large phase error that is unable to accurately (<1°) and continuously measure phase due to the square-wave modulation scheme of the current generator [3], resulting in intolerable measurement errors [2], or the supply and temperature variations of measurement accuracy due to the limited bandwidth (BW) of readout [2]. Although the pre-demodulation [3] technique can relax BW requirement, conversion loss of sine to square wave demodulation causes SNR degradation by 2/π times, leading to 2.47× increased power consumption.
Date of Conference: 17-21 February 2019
Date Added to IEEE Xplore: 07 March 2019
ISBN Information: